Relationship between evaluation by quantitative fatty acid myocardial scintigraphy and response to β-blockade therapy in patients with dilated cardiomyopathy

European Journal of Nuclear Medicine

Volumn 28, Issue 12, 2001, Pages 1811-1816

  Ito, T ^a   Hoshida, S ^a   Nishino, M ^a   Aoi, T ^a   Egami, Y ^a   Takeda, T ^a   Kawabata, M ^a   Tanouchi, J ^a   Yamada, Y ^a   Kamada, T ^a  

^a OSAKA ROSAI HOSPITAL   (Japan)

Author keywords

Blockade therapy; 15 (p iodophenyl) 3 R,S methylpentadecanoic acid; Dilated cardiomyopathy

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FATTY ACID; METOPROLOL;

ACCURACY; ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FATTY ACID METABOLISM; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE INJURY; HEART SCINTISCANNING; HUMAN; MALE; PREDICTION; QUANTITATIVE ASSAY; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; CARDIOMYOPATHY, DILATED; FATTY ACIDS; FEMALE; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; METOPROLOL; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0035208258     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-001-0668-2     Document Type: Article

References (26)

1. New radioiodinated methyl-branched fatty acids for cardiac studies
2. 123I-BMIPP)
3. Basic kinetics of 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in canine myocardium
4. Evaluation of the metabolism in rat heart of two new radioiodinated 3-methyl-branched fatty acid myocardial imaging agents
5. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: Assessment with emission tomography using an iodinated branched fatty acid analog
6. 201Tl SPET Images
7. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy
8. Discrepancies between myocardial perfusion and free fatty acid metabolism in patients with hypertrophic cardiomyopathy
9. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy
10. 123I]iodoheptadecanoic acid in patients with idiopathic congestive cardiomyopathy
11. Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography
12. 123I-BMIPP scintigraphy and left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy
13. Therapeutic effect of co-enzyme Q10 on idiopathic dilated cardio-myopathy: Assessment by iodine-123 labelled 15-(p-iodophe-nyl)-3(R,S)-methylpentadecanoic acid myocardial single-photon emission tomography
14. Predicting the effects on patients with dilated cardiomyopathy of beta-blocker therapy, by using iodine-123 15-(p-iodophenyl)-3-R,S-methyl-pentadecanoic acid (BMIPP) myocardial scintigraphy
15. 123I BMIPP SPECT: Correlation with clinicopathological findings and clinical course
16. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy
17. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
18. A randomized trial of beta-blockade in heart failure
19. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
20. Basic principles of ROC analysis
21. Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy
22. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy
23. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methylpenta-decanoic acid (BMIPP), in relation to ATP concentration
24. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model
25. Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure
26. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy